SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px
Organisation › Details

PathoQuest S.A.S.

PathoQuest is a spin-off of the Pasteur Institute and the ENVA (Ecole Nationale Vétérinaire d'Alfort). PathoQuest is a new generation molecular diagnostics company that offers a unique approach in infectious diseases diagnostics. Developing disruptive approaches that combine sample prep technology and cloud-based bioinformatics, PathoQuest is committed to achieving the first clinical demonstration of an NGS-Saas (Next Generation Sequencing Software as a Service) based diagnostic assay through a clinical trial vs current diagnostic approaches both in the US and the EU. Ultimately, PathoQuest aims to be one of the first e-healthcare companies offering essential nonbiased diagnostic approaches for clinicians to prescribe personalized medicine. *


Period Start 2010-09-01 splitoff
  Predecessor Institut Pasteur
Products Industry molecular diagnostics
  Industry 2 iDTECT™ Blood test
Persons Person Brepson, Jean-Francois (PathoQuest 201610 CEO)
  Person 2 Eloit, Marc (PathoQuest 201103 CSO)
Region Region Paris
  Country France
  Street 28 rue du Docteur Roux
  City 75015 Paris
    Address record changed: 2013-07-11
Basic data Employees n. a.
    * Document for �About Section�: PathoQuest S.A.S.. (7/11/13). "Press Release: PathoQuest Raises EUR 3.8 Million in Series B Financing Round". Paris.
Record changed: 2019-01-14


Picture [LSUS] – The Business Web Portal 600x60px

More documents for PathoQuest S.A.S.

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px

» top